Cargando…
Dual antiplatelet therapy for coronary and peripheral arterial disease /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam :
Academic Press,
2021.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- <Ol> <li>Platelets and arterial disease
- initiation, progression and destabilization of atherosclerotic vascular disease</li> <p> <li>Platelet physiology and pharmacology
- relevant considerations for patient care</li> <p> <li>The development of dual antiplatelet therapy
- physiologic and clinical implications of multiple pathway inhibition of platelet function</li> <p> <li>Acute coronary syndromes and percutaneous coronary intervention
- current recommendations for dual antiplatelet therapy. Are guidelines reflecting the data?</li> <p> <li>Peripheral arterial disease
- a different kind of arterial disease? The role of antiplatelet therapy in prevention and treatment of limb ischemia</li> <p> <li>Cerebrovascular disease
- what is the role of DAPT for prevention and treatment of ischemic stroke?</li> <p> <li>Competing risks in DAPT duration of therapy
- the case for shorter treatment</li> <p> <li>DAPT may prevent coronary ischemic events beyond one year
- the case for extended DAPT treatment</li> <p> <li>How to integrate risk of bleeding and ischemic events in clinical medicine? The role of risk scores </li> <p> <li>Moving from DAPT to monotherapy based on P2Y12 receptor blockade
- why it could be a novel paradigm?</li> <p> <li>The conundrum of simultaneous antiplatelet and antithrombotic therapy
- how to resolve it?</li> <p> <li>A look to the future </li> </ol>